2024 Online Tour: Join Yili on Journey of Quality in New Zealand2024 Online Tour: Join Yili on Journey of Quality in New Zealand PR Newswire
||
TIMARU, New Zealand, Oct. 10, 2024 /PRNewswire/ — New Zealand, renowned for its pristine landscapes and high-quality dairy products, has long been a global leader in the dairy industry.... 
Indonesia Episode of Yili’s 2024 Online Tour Now Available!Indonesia Episode of Yili’s 2024 Online Tour Now Available! PR Newswire
||
JAKARTA, Indonesia, Oct. 11, 2024 /PRNewswire/ — Indonesia, the Land of a Thousand Islands, stretches across the equator, boasting a stunning collection of over 17,000 islands. Its natural beauty... 
Thailand Episode of Yili’s 2024 Online Tour: Unveiling Cremo’s Success StoryThailand Episode of Yili’s 2024 Online Tour: Unveiling Cremo’s Success Story PR Newswire
||
BANGKOK, Oct. 10, 2024 /PRNewswire/ — Yili’s 2024 Online Tour makes its second stop in Thailand. Join us on a virtual journey through the Land of Smiles to discover... Start of Day MessageStart of Day Message GlobeNewswire
||
LONDON, 11 Oct. 2024 (GLOBE NEWSWIRE) — This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an... 
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolioSandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio GlobeNewswire
||
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for metastatic breast cancerLaunch expected to be near-term growth driver... 
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual MeetingNMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting GlobeNewswire
||
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma... 
Digital subscription results of AS Ekspress Grupp in the third quarter of 2024Digital subscription results of AS Ekspress Grupp in the third quarter of 2024 GlobeNewswire
||
The number of digital subscriptions of AS Ekspress Grupp increased by 24% in the Baltic States year-over-year (3rd quarter: 0%, 9 months: 7%) and totalled 222 611 at the end... Waterdrop Inc. Released 2023 ESG Report: Adhere to both Sci-tech Innovation and Social ResponsibilityWaterdrop Inc. Released 2023 ESG Report: Adhere to both Sci-tech Innovation and Social Responsibility PR Newswire
||
BEIJING, Oct. 11, 2024 /PRNewswire/ — Waterdrop Inc. released its Environmental, Social and Governance (ESG) Report 2023 (“the Report”) in October. The Report details Waterdrop Inc.’s efforts in a... 
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutationFDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GlobeNewswire
||
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting1This approval... 
GMO Payment Gateway, Inc. Invests USD 3 Million in Helicap’s Flagship Credit Fund to Drive Growth of FinTech in Southeast AsiaGMO Payment Gateway, Inc. Invests USD 3 Million in Helicap’s Flagship Credit Fund to Drive Growth of FinTech in Southeast Asia PR Newswire
||
SINGAPORE, Oct. 11, 2024 /PRNewswire/ — Helicap Group is proud to announce that GMO Payment Gateway, Inc. (TSE Prime Market Securities Code: 3769, President & CEO: Issei Ainoura), a...